GSK China To Delink Sale Reps’ Pay To Sales; Stops Subsidizing Doc Events
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline China announced plans to drop the link between sales figures and compensation for sales representatives and subsidies for medical conferences for physicians.